NO995419L - Intravaginale anordninger for legemiddelavlevering for administrering av testosteron og testosteron-forløpere - Google Patents
Intravaginale anordninger for legemiddelavlevering for administrering av testosteron og testosteron-forløpereInfo
- Publication number
- NO995419L NO995419L NO995419A NO995419A NO995419L NO 995419 L NO995419 L NO 995419L NO 995419 A NO995419 A NO 995419A NO 995419 A NO995419 A NO 995419A NO 995419 L NO995419 L NO 995419L
- Authority
- NO
- Norway
- Prior art keywords
- testosterone
- administration
- drug delivery
- delivery devices
- precursors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE970333 | 1997-05-07 | ||
PCT/IE1998/000033 WO1998050016A2 (en) | 1997-05-07 | 1998-05-07 | Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO995419D0 NO995419D0 (no) | 1999-11-05 |
NO995419L true NO995419L (no) | 2000-01-07 |
Family
ID=11041465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO995419A NO995419L (no) | 1997-05-07 | 1999-11-05 | Intravaginale anordninger for legemiddelavlevering for administrering av testosteron og testosteron-forløpere |
Country Status (15)
Country | Link |
---|---|
US (1) | US6416780B1 (no) |
EP (1) | EP0981327B1 (no) |
JP (1) | JP2001524124A (no) |
CN (1) | CN1184957C (no) |
AT (1) | ATE227120T1 (no) |
AU (1) | AU741482B2 (no) |
CA (1) | CA2288046C (no) |
DE (1) | DE69809222T2 (no) |
DK (1) | DK0981327T3 (no) |
ES (1) | ES2187024T3 (no) |
IL (1) | IL132702A0 (no) |
NO (1) | NO995419L (no) |
NZ (1) | NZ501236A (no) |
PT (1) | PT981327E (no) |
WO (1) | WO1998050016A2 (no) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
ES2388731T5 (es) | 2002-03-27 | 2018-01-19 | Warner Chilcott (Ireland) Limited | Dispositivos de administración de fármacos mediante una matriz intravaginal |
US8399013B2 (en) * | 2003-06-26 | 2013-03-19 | Poly-Med, Inc. | Partially absorbable fiber-reinforced composites for controlled drug delivery |
US8404272B2 (en) | 2003-06-26 | 2013-03-26 | Poly-Med, Inc. | Fiber-reinforced composite rings for intravaginal controlled drug delivery |
US7922702B2 (en) | 2004-07-02 | 2011-04-12 | Qlt Inc. | Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device |
MY145694A (en) | 2005-04-11 | 2012-03-30 | Xenon Pharmaceuticals Inc | Spiroheterocyclic compounds and their uses as therapeutic agents |
MY158766A (en) | 2005-04-11 | 2016-11-15 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
ES2400091T3 (es) * | 2005-08-11 | 2013-04-05 | Massachusetts Institute Of Technology | Dispositivo de suministro de fármacos intravesical y método |
AU2007234445B2 (en) | 2006-03-31 | 2011-07-21 | Mati Therapeutics Inc. | Nasolacrimal drainage system implants for drug therapy |
EP2073806B1 (en) | 2006-10-12 | 2012-02-15 | Xenon Pharmaceuticals Inc. | Use of spiro-oxindole compounds as therapeutic agents |
ES2481454T3 (es) | 2007-12-11 | 2014-07-30 | Massachusetts Institute Of Technology | Dispositivo implantable de administración de fármacos |
DK2249757T3 (en) | 2008-02-04 | 2017-10-16 | Ferring Bv | Monolithic vaginal rings comprising progesterone and methods of preparation and use thereof. |
US9034365B2 (en) | 2008-05-20 | 2015-05-19 | Poly-Med, Inc. | Biostable, multipurpose, microbicidal intravaginal devices |
KR101689786B1 (ko) | 2008-08-09 | 2016-12-26 | 메사츄세츠 인스티튜트 어브 테크놀로지 | 남성 비뇨생식기 및 주위 조직을 치료하는 방법 및 체내이식형 약물 전달 장치 |
CA2741029A1 (en) | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
WO2010045197A1 (en) | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals, Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
US20110269788A1 (en) | 2008-12-29 | 2011-11-03 | Xenon Pharmaceuticals Inc. | Spiro-oxindole-derivatives as sodium channel blockers |
WO2010151893A1 (en) | 2009-06-26 | 2010-12-29 | Taris Biomedical, Inc. | Implantable drug delivery devices and methods of making the same |
AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
US9017312B2 (en) * | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
US8445696B2 (en) | 2009-10-14 | 2013-05-21 | Xenon Pharmaceuticals Inc. | Synthetic methods for spiro-oxindole compounds |
CN102946859B (zh) | 2010-02-26 | 2016-03-02 | 泽农医药公司 | 用于局部给药的螺-羟吲哚化合物的药物组合物及其作为治疗剂的用途 |
JP2014503554A (ja) | 2011-01-10 | 2014-02-13 | タリス バイオメディカル,インコーポレイテッド | 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン |
ES2637388T3 (es) | 2011-02-04 | 2017-10-13 | Taris Biomedical, Inc. | Dispositivo implantable para la liberación controlada de un fármaco de baja solubilidad |
US9974685B2 (en) | 2011-08-29 | 2018-05-22 | Mati Therapeutics | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension |
WO2013030679A2 (en) | 2011-08-29 | 2013-03-07 | Qlt Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
WO2013064983A1 (en) | 2011-10-31 | 2013-05-10 | Xenon Pharmaceuticals Inc. | Benzenesulfonamide compounds and their use as therapeutic agents |
AU2014228858A1 (en) | 2013-03-15 | 2015-09-10 | The Regents Of The University Of California | Dual reactivity potent Kunitz inhibitor of fibrinolysis |
KR102293280B1 (ko) | 2013-03-15 | 2021-08-23 | 타리스 바이오메디컬 엘엘씨 | 약물-투과성 구성요소를 가지는 약물 전달 장치 및 방법 |
IL299897B2 (en) | 2013-08-19 | 2024-02-01 | Taris Biomedical Llc | Devices and methods for administering multiple units of drug |
CN104546668B (zh) * | 2013-10-23 | 2019-03-05 | 国家卫生计生委科学技术研究所 | 液体硅橡胶为载体的药物缓控释系统的制备及应用 |
KR20170021929A (ko) * | 2014-06-28 | 2017-03-02 | 라보라토리오스 안드로마코 에스.에이. | 조산 예방에 유용한 지속적, 서방성, 및 연속 방출의 프로게스테론 함유 원형 결찰 페서리 |
US9682033B2 (en) | 2015-02-05 | 2017-06-20 | Teva Pharmaceuticals International Gmbh | Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound |
JP7425534B2 (ja) | 2015-04-23 | 2024-01-31 | タリス バイオメディカル エルエルシー | 薬物透過性構成要素を有する薬物送達デバイス及び方法 |
DK3416964T3 (da) | 2016-02-19 | 2021-02-22 | Phoenix Molecular Designs | 6-Oxo-N-(1-(benzyl)-1H-pyrazol-4-YL)-6,7,8,9-tetrahydropyrido[3',2':4,5]pyrrolo[1,2-A]pyrazin-2-carboxamid-derivater som P90 ribosomal S6 kinase- (RSK-) hæmmere til behandling af cancer |
WO2017201468A1 (en) | 2016-05-20 | 2017-11-23 | Xenon Pharmaceuticals Inc. | Benzenesulfonamide compounds and their use as therapeutic agents |
CN110325531B (zh) | 2016-12-09 | 2022-05-27 | 泽农医药公司 | 苯磺酰胺及其作为治疗剂的用途 |
CR20200613A (es) | 2018-06-13 | 2021-06-10 | Xenon Pharmaceuticals Inc | Compuestos de bencenosulfonamida y su uso como agentes terapéuticos |
CR20210095A (es) | 2018-07-27 | 2021-06-01 | Xenon Pharmaceuticals Inc | Metodo para tratar la epilepsia |
CN112638898B (zh) | 2018-08-31 | 2024-04-09 | 泽农医药公司 | 杂芳基取代的磺酰胺化合物及其作为钠通道抑制剂的用途 |
JOP20200337A1 (ar) | 2018-08-31 | 2020-12-24 | Xenon Pharmaceuticals Inc | مركبات سولفوناميد بها استبدال بأريل غير متجانس واستخدامها كعوامل علاجية |
US11813354B1 (en) | 2019-01-11 | 2023-11-14 | Shear Kershman Laboratories, Inc | Trans-mucosal delivery system for testosterone |
WO2020165646A1 (en) | 2019-02-11 | 2020-08-20 | Phoenix Molecular Designs | Crystalline forms of an rsk inhibitor |
MX2024003645A (es) | 2021-09-24 | 2024-06-04 | Xenon Pharmaceuticals Inc | Derivados de piridinilacetamida como activadores de canales de sodio. |
CN118284602A (zh) | 2021-09-24 | 2024-07-02 | 泽农医药公司 | 作为钠通道活化剂的吡啶衍生物及其用途 |
IL311056A (en) | 2021-09-24 | 2024-04-01 | Xenon Pharmaceuticals Inc | Pyridine derivatives as sodium channel activators |
WO2023239729A1 (en) | 2022-06-08 | 2023-12-14 | Xenon Pharmaceuticals Inc. | Pyridinamine derivatives and their use as potassium channel modulators |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3920805A (en) | 1971-12-09 | 1975-11-18 | Upjohn Co | Pharmaceutical devices and method |
AU538961B2 (en) * | 1980-06-09 | 1984-09-06 | Alex Harvey Industries Limited | Intra-vaginal device |
US5340585A (en) * | 1991-04-12 | 1994-08-23 | University Of Southern California | Method and formulations for use in treating benign gynecological disorders |
IL116433A (en) | 1994-12-19 | 2002-02-10 | Galen Chemicals Ltd | INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS |
-
1998
- 1998-05-07 AU AU74469/98A patent/AU741482B2/en not_active Expired
- 1998-05-07 PT PT98921701T patent/PT981327E/pt unknown
- 1998-05-07 DK DK98921701T patent/DK0981327T3/da active
- 1998-05-07 EP EP98921701A patent/EP0981327B1/en not_active Expired - Lifetime
- 1998-05-07 WO PCT/IE1998/000033 patent/WO1998050016A2/en active IP Right Grant
- 1998-05-07 US US09/423,324 patent/US6416780B1/en not_active Expired - Lifetime
- 1998-05-07 ES ES98921701T patent/ES2187024T3/es not_active Expired - Lifetime
- 1998-05-07 AT AT98921701T patent/ATE227120T1/de not_active IP Right Cessation
- 1998-05-07 JP JP54787898A patent/JP2001524124A/ja active Pending
- 1998-05-07 CA CA002288046A patent/CA2288046C/en not_active Expired - Fee Related
- 1998-05-07 CN CNB988049139A patent/CN1184957C/zh not_active Expired - Lifetime
- 1998-05-07 DE DE69809222T patent/DE69809222T2/de not_active Expired - Lifetime
- 1998-05-07 IL IL13270298A patent/IL132702A0/xx not_active IP Right Cessation
- 1998-05-07 NZ NZ501236A patent/NZ501236A/en not_active IP Right Cessation
-
1999
- 1999-11-05 NO NO995419A patent/NO995419L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2001524124A (ja) | 2001-11-27 |
AU741482B2 (en) | 2001-11-29 |
ATE227120T1 (de) | 2002-11-15 |
ES2187024T3 (es) | 2003-05-16 |
DE69809222D1 (de) | 2002-12-12 |
CN1255056A (zh) | 2000-05-31 |
CA2288046C (en) | 2006-10-03 |
EP0981327B1 (en) | 2002-11-06 |
WO1998050016A2 (en) | 1998-11-12 |
CA2288046A1 (en) | 1998-11-12 |
CN1184957C (zh) | 2005-01-19 |
DE69809222T2 (de) | 2003-08-14 |
NO995419D0 (no) | 1999-11-05 |
IL132702A0 (en) | 2001-03-19 |
DK0981327T3 (da) | 2003-03-10 |
NZ501236A (en) | 2002-02-01 |
AU7446998A (en) | 1998-11-27 |
US6416780B1 (en) | 2002-07-09 |
EP0981327A2 (en) | 2000-03-01 |
PT981327E (pt) | 2003-02-28 |
WO1998050016A3 (en) | 1999-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO995419D0 (no) | Intravaginale anordninger for legemiddelavlevering for administrering av testosteron og testosteron-forlöpere | |
AU1227899A (en) | Osmotic medicament releasing system | |
GB2341550A (en) | Gastroretentive controlled release microspheres for improved drug delivery | |
WO2003077972A8 (en) | Implantable drug delivery system | |
PT841903E (pt) | Composicao farmaceutica oral contendo agentes activos antimicrobianos e pantoprazole com libertacao diferida | |
WO2003028660A3 (en) | Drug delivery devices and methods | |
GB2338414A (en) | Intravesical drug delivery system | |
ID21259A (id) | Sistim penyaluran obat untuk dua atau lebih bahan-bahan aktif | |
BR0215262A (pt) | Formas de dosagem com liberação sustentada de ordem zero e processo para a fabricação das mesmas | |
HUP9902477A3 (en) | Sustained delivery device and system of an active agent using an implantable system and method for producing of the device; a back-diffusion regulating outlet and a semipermeable plug | |
EP1504758A3 (en) | Controlled-release formulations coated with aqueous dispersions of ethylcellulose | |
AU4399196A (en) | Intravaginal drug delivery devices for the administration of 17beta -oestradiol precursors | |
PT1017391E (pt) | Formulacao de comprimidos de libertacao prolongada para tratar a doenca de parkinson | |
AR036972A1 (es) | Tableta bioadhesiva de hidratacion progresiva y liberacion sostenida y su uso en la fabricacion de un agente farmaceutico | |
EP1499300A4 (en) | PHARMACEUTICAL FORMULATIONS WITH IMPROVED BIOAVAILABILITY | |
ATE391495T1 (de) | Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe | |
HK1032010A1 (en) | Medicament formulation with a controlled release of an active agent. | |
WO1998026767A3 (en) | Site-specific controlled release dosage formulation for mesalamine | |
AU1495595A (en) | Sustained-release dosage forms of alfuzosin hydrochloride | |
HK1060691A1 (en) | Ion-strength independent sustained release pharmaceutical formulation | |
HRP20010684B1 (en) | Directly compressible matrix for controlled release of single daily doses of clarithromycin | |
EP1106609A3 (en) | Aminoalcohol derivative and medicament comprising the same | |
WO2002053149A3 (de) | Arzneimittel enthaltend ein polyamin als wirksubstanz | |
NZ324674A (en) | Rapid release tablet comprising tolfenamic acid, alginic acid and a superdisintegrant | |
BG106342A (en) | Low-dose tablets and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |